What does RECHERCHE ET SANTE do?

RECHERCHE ET SANTE is a research organisation in Waterloo. Private Limited, started on 1 November 1977, 1 establishment.

What is the address of RECHERCHE ET SANTE?

The registered office of RECHERCHE ET SANTE is located at Rue du Ménil 26, 1410 Waterloo.

Is RECHERCHE ET SANTE still active?

Yes. According to the CBE (31 October 2026) RECHERCHE ET SANTE is active, legal situation “Normale toestand”, started on 1 November 1977.

Is RECHERCHE ET SANTE registered on Peppol?

Yes, RECHERCHE ET SANTE is registered on the Peppol network with ID 0208:0417663192.

What is the enterprise number of RECHERCHE ET SANTE?

The enterprise number of RECHERCHE ET SANTE is BE0417663192.

When was RECHERCHE ET SANTE founded?

RECHERCHE ET SANTE was founded on 1 November 1977.

Is RECHERCHE ET SANTE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 November 1977; 5 annual accounts filed, latest fiscal year 2025.

How much profit did RECHERCHE ET SANTE make in 2025?

RECHERCHE ET SANTE posted a profit after taxes of € 2,964 in financial year 2025.

What is the revenue of RECHERCHE ET SANTE?

As a small company, RECHERCHE ET SANTE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 4,517.

RECHERCHE ET SANTE (Private Limited) - Waterloo

Dossier RECHERCHE ET SANTE, printed on 31 October 2026 from databakkes.be/en/0417663192/recherche-et-sante. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

RECHERCHE ET SANTE from Waterloo, company number BE0417663192, closed financial year 2025 with a result of € 2,964 after tax. For that financial year RECHERCHE ET SANTE recorded a gross margin of € 4,517 and equity of € 73,168. Compared with financial year 2024, the result moved from € 2,550 to € 2,964. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.

What it is worth Growing

€ 73,168

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 2,964

▲ 16% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 42,061

▲ 99% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 859 paid out

29 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 310

▼ 48% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 113

Loans from banks and other lenders, long and short.

Taxes

€ 1,178

▼ 15% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 5,025 Gross margin 2022: € 5,025 First fiscal year in the series	€ 1,451 Gross margin 2023: € 1,451 ▼ 71% vs 2022 (€ 5,025) Unfavourable step	€ 4,085 Gross margin 2024: € 4,085 ▲ 181% vs 2023 (€ 1,451) Favourable step	€ 4,517 Gross margin 2025: € 4,517 ▲ 11% vs 2024 (€ 4,085) Favourable step	▲ 11%
Profit after taxes	€ 1,542 Profit after taxes 2022: € 1,542 First fiscal year in the series	€ -4,457 Profit after taxes 2023: € -4,457 ▼ € 5,999 vs 2022 (€ 1,542) Unfavourable step	€ 2,550 Profit after taxes 2024: € 2,550 ▲ € 7,007 vs 2023 (€ -4,457) Favourable step	€ 2,964 Profit after taxes 2025: € 2,964 ▲ 16% vs 2024 (€ 2,550) Favourable step	▲ 16%
Equity	€ 72,970 Equity 2022: € 72,970 First fiscal year in the series	€ 68,513 Equity 2023: € 68,513 ▼ 6% vs 2022 (€ 72,970) Unfavourable step	€ 71,063 Equity 2024: € 71,063 ▲ 4% vs 2023 (€ 68,513) Favourable step	€ 73,168 Equity 2025: € 73,168 ▲ 3% vs 2024 (€ 71,063) Favourable step	▲ 3%
Total debts	€ 35,660 Total debts 2022: € 35,660 First fiscal year in the series	€ 550 Total debts 2023: € 550 ▼ 98% vs 2022 (€ 35,660) Favourable step	€ 1,499 Total debts 2024: € 1,499 ▲ 173% vs 2023 (€ 550) Unfavourable step	€ 2,006 Total debts 2025: € 2,006 ▲ 34% vs 2024 (€ 1,499) Unfavourable step	▲ 34%
Cash	€ 2,317 Cash 2022: € 2,317 First fiscal year in the series	€ 49,157 Cash 2023: € 49,157 ▲ € 46,840 vs 2022 (€ 2,317) Favourable step	€ 21,098 Cash 2024: € 21,098 ▼ 57% vs 2023 (€ 49,157) Unfavourable step	€ 42,061 Cash 2025: € 42,061 ▲ 99% vs 2024 (€ 21,098) Favourable step	▲ 99%
Retained profit	€ 10,970 Retained profit 2022: € 10,970 First fiscal year in the series	€ 6,513 Retained profit 2023: € 6,513 ▼ 41% vs 2022 (€ 10,970) Unfavourable step	€ 9,063 Retained profit 2024: € 9,063 ▲ 39% vs 2023 (€ 6,513) Favourable step	€ 11,168 Retained profit 2025: € 11,168 ▲ 23% vs 2024 (€ 9,063) Favourable step	▲ 23%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 800) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 859 Dividend 2025: € 859 Unchanged (€ 0) Unchanged
Bank debt	€ 30,271 Bank debt 2022: € 30,271 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 30,271) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 113 Bank debt 2025: € 113 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 108,630 Balance sheet total 2022: € 108,630 First fiscal year in the series	€ 69,063 Balance sheet total 2023: € 69,063 ▼ 36% vs 2022 (€ 108,630) Unchanged	€ 72,562 Balance sheet total 2024: € 72,562 ▲ 5% vs 2023 (€ 69,063) Unchanged	€ 75,174 Balance sheet total 2025: € 75,174 ▲ 4% vs 2024 (€ 72,562) Unchanged	▲ 4%

Key figures of RECHERCHE ET SANTE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to RECHERCHE ET SANTE?

What happened at RECHERCHE ET SANTE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 15, 2026 New annual accounts for financial year 2025: profit of € 2,964 (▲ 16% vs 2024). Source: NBB ↗
Oct 6, 2008 New establishment in Waterloo. KBO
Nov 1, 1977 Start of the company according to the CBE. KBO

In short

From € 1,542 profit in 2022 to € 2,964 profit in 2025.

Paid € 1,356 in corporate taxes since 2022.

Best year ever: 2025, with € 2,964 profit.

Paid out € 1,659 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Ménil 26

1410 Waterloo

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0417.663.192

VAT number

BE 0417.663.192

Registered office

Rue du Ménil 26, 1410 Waterloo

Names & denominations

RECHERCHE ET SANTE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 November 1977

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied